Sponsor: National Institute of Mental Health
Objective: Cognitive behavior therapy (CBT) is an effective treatment for anxiety and fear-related disorders. However, some patients fail to achieve complete remission or show a return of anxiety symptoms following treatment. The purpose of the study is to determine the extent to which one’s emotional reaction to a CO2 inhalation task can help predict who might or might not respond to therapy. If CO2 reactivity proves to be successful in predicting who will benefit from CBT versus who will not, clinicians can make better decisions about which patients should be treated with CBT
Clinical Trials Registry: Click here.
Status: This study is currently recruiting participants.
IRB Protocol: 2016-09-0150
Learn how to participate

Objective: This study aims to examine the effectiveness of a large-group intervention designed to target anxiety sensitivity or the fear of anxiety and related sensations. Additionally, examining the feasibility of establishing an exposure therapy consortium is another central aim of this study. An exposure therapy consortium may help formalize efforts to better study mechanisms of action and optimization strategies, thereby aiding the goal of improving exposure efficacy and implementation of exposure therapy.
Clinical Trials Registry: Click here.
Status: This study is currently recruiting participants.
IRB Protocol: 2019-09-0153